| #154 |
Peter Matusov |
Slantrange |
1 |
| #154 |
Reuben J. Shaw |
Salk Institute For Biological Studies |
1 |
| #154 |
Matthew Chun |
Salk Institute For Biological Studies |
1 |
| #154 |
Sophie Perrin-Ninkovic |
Signal Pharmaceuticals |
1 |
| #154 |
Zoran Radic |
University of California |
1 |
| #154 |
Santhi R. Ganji |
Sanford Burnham Prebys Medical Discovery Institute |
1 |
| #154 |
Annette Von Drygalski |
University of California |
1 |
| #154 |
Jacob Neal Beverage |
— |
1 |
| #154 |
Phillip Ordoukhanian |
Scripps Research |
1 |
| #154 |
Rajesh Mukthavaram |
Arcturus Therapeutics |
1 |
| #154 |
Christopher J. Soares |
Amylin Pharmaceuticals |
1 |
| #154 |
Brian Campion |
Biophysica |
1 |
| #154 |
Brian Adamson |
University of California |
1 |
| #154 |
Yunting Zhao |
University of California |
1 |
| #154 |
Richard A. Lerner |
Scripps Research |
1 |
| #154 |
Ross Rudolph |
Spire |
1 |
| #154 |
Ryan Kastner |
University of California |
1 |
| #154 |
Juliesta Elaine Sylvester |
Molecular Assemblies |
1 |
| #154 |
Marianne Marcela Andrea Martinic |
Pfizer |
1 |
| #154 |
Peter TERIETE |
Salk Institute For Biological Studies |
1 |
| #154 |
Xiaowu Liang |
Immport Therapeutics |
1 |
| #154 |
Marc R. Montminy |
Salk Institute For Biological Studies |
1 |
| #154 |
Charlie Gunderson |
Drivecam |
1 |
| #154 |
Peter Yanofsky |
— |
1 |
| #154 |
Marcela Mendoza |
Salk Institute For Biological Studies |
1 |
| #154 |
John D. H. King |
Boston Scientific |
1 |
| #154 |
Clive W.R. Cooper |
Tierravision |
1 |
| #154 |
Samir Chowdhury |
Siemens Medical Solutions Usa |
1 |
| #154 |
Alex Battaglia |
— |
1 |
| #154 |
Clyde A. Hutchison |
Synthetic Genomics |
1 |
| #154 |
Andrew Hollands |
Inhibrx |
1 |
| #154 |
H. Kirk Hammond |
University of California |
1 |
| #154 |
Jose Luis Millan |
Sanford-Burnham Medical Research Institute |
1 |
| #154 |
Vishal Deshmukh |
Scripps Research |
1 |
| #154 |
Paul D. van Poelje |
Metabasis Therapeutics |
1 |
| #154 |
Tara Stevenson |
Nuvasive |
1 |
| #154 |
Justin Chakma |
Auspex Pharmaceuticals |
1 |
| #154 |
John D. Dobak, III |
Innercool Therapies |
1 |
| #154 |
Victor Bronshtein |
Comcast |
1 |
| #154 |
Philip Weyman |
Zymergen |
1 |
| #154 |
Janusz Sowadski |
Beth Israel Deaconess Medical Center |
1 |
| #154 |
Osman Kibar |
Biosplice Therapeutics |
1 |
| #154 |
Lucas Rascon |
Inhibrx Biosciences |
1 |
| #154 |
Chixu Chen |
Sgx Pharmaceuticals |
1 |
| #154 |
Mariangela Urbano |
Scripps Research |
1 |
| #154 |
Bryan T. Oronsky |
Epicentrx |
1 |
| #154 |
Nunzio Bottini |
La Jolla Institute For Allergy And Immunology |
1 |
| #154 |
Harinath Garudadri |
Qualcomm |
1 |
| #154 |
Shawn Griffis |
Szent |
1 |
| #154 |
Sara S. Hadida Ruah |
Sumitomo Pharmaceuticals Company Limited |
1 |